ClinicalTrials.gov
ClinicalTrials.gov Menu

Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00396643
Recruitment Status : Completed
First Posted : November 7, 2006
Last Update Posted : December 27, 2007
Sponsor:
Collaborator:
Stanley Medical Research Institute
Information provided by:
Medical University of Vienna

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2007
  Actual Study Completion Date : June 2007
Publications:
Berger GE, Proffitt TM, McConchie M, et al. Ethyl-Eicosapentaenoic acid in first episode psychosis: A randomized, placebo-controlled trial. Journal of Clinical Psychiatry 2007; in press Berger GE, Wood SJ, Wellard RM, et al. In vivo brain effects of ethyl-eicosapentaenoic acid in early psychosis. A 1H-MRS study. Neuropsychopharmacology 2007;in press.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):